Autolomous, a developer of critical manufacturing management systems for cell and gene therapies, and Vineti, a provider of digital enterprise platforms for cell and gene therapy supply chains, have announced a non-exclusive, collaborative partnership.
The collaboration will integrate Autolomous’ critical manufacturing management systems with Vineti’s Personalized Therapy Management (PTM) platform. This will allow both parties to create a seamless end-to-end cell and gene therapy (CGT) delivery pathway, including critical inbound and outbound manufacturing value processes, which will result in an increase in the visibility and dynamic exchange of information to and from stakeholders across the CGT value chain. The partnership will ensure they can react to unpredictable variables related to working on biological processes. The integration of the technologies will also enable scaling up of marketing by increasing transparency, compliance, and auditability while delivering significant savings in time and resources from efficiency gains.
Vineti has developed its Chain of Identity (CoI) and Chain of Custody (CoC) systems to be vital elements of the cell and gene therapy value chain. The critical nature of these systems specifically within this sector is because visibility and security of value and supply chains must be maintained throughout, from the procurement of patient material to the delivery of drug products. These supply chains will become increasingly complex as the number of available therapies and treated patients continues to rise.
“Partnering with Autolomous will allow Vineti to expand its provision across the CGT value chain. The integration of both organizations’ technology will give Vineti additional tools to satisfy the rising procurement and delivery demands of the CGT sector,” said Vineti CEO and Co-founder Amy DuRoss. “Both companies are specialized within the heart of the CGT value chain and have delivered outputs that have made considerable and tangible cross-sector enhancements. The collaboration between Autolomous and Vineti will enable the provision of solutions required by the industry as it reaches a much larger scale.”
See the original press release on Globe Newswire.
See further coverage in: